What makes FloraGLO Lutein Max different from regular lutein supplements?

FloraGLO Lutein Max provides lutein in free-form rather than lutein ester form, meaning it does not require saponification (ester bond cleavage) during digestion before absorption. This structural distinction is associated with faster and more predictable micellarization and uptake via SR-B1 receptors in the small intestine, potentially resulting in higher and more consistent plasma lutein levels compared to ester-based products.

What is the recommended dosage of FloraGLO Lutein Max for eye health?

The most widely studied and cited effective dose for lutein in eye health research is 10 mg/day, as used in the AREDS2 trial, which demonstrated a 26% reduction in AMD progression risk. Some studies examining macular pigment optical density (MPOD) improvements have used doses up to 20 mg/day. Doses exceeding 20 mg/day have not demonstrated additional benefit and are not standard clinical recommendations.

How long does it take for FloraGLO Lutein to improve macular pigment levels?

Based on general free-form lutein research, measurable increases in macular pigment optical density (MPOD) typically require 3 to 6 months of consistent daily supplementation at 10–20 mg/day. Individual response varies based on baseline dietary lutein intake, genetic polymorphisms in carotenoid transport proteins like GSTP1, and overall dietary fat intake, which is necessary for carotenoid absorption.

Can FloraGLO Lutein help with blue light protection from screens?

Lutein absorbs blue-range light between approximately 400–500 nm, overlapping with the emission spectrum of LED and digital screens. By increasing macular pigment optical density through supplementation, lutein provides a modest endogenous optical filter at the retinal level. While this biological mechanism is well-established, specific clinical trials quantifying screen-related visual fatigue reduction with FloraGLO Lutein Max as the tested form are not yet sufficiently documented in the available literature.

Is FloraGLO Lutein Max safe to take with zeaxanthin?

Lutein and zeaxanthin are co-occurring macular carotenoids that are commonly combined in eye health supplements, as done in the AREDS2 formulation (10 mg lutein / 2 mg zeaxanthin), where the combination showed a favorable safety profile over five years in over 4,000 participants. Both carotenoids compete for the same intestinal absorption pathway, so using ratios approximating those found in dietary sources and clinical trials (roughly 5:1 lutein to zeaxanthin) is recommended to avoid displacing either compound from retinal tissue.

What is the source of FloraGLO Lutein Max and how is it extracted?

FloraGLO Lutein Max is derived from Tagetes erecta (marigold flowers) through proprietary extraction and manufacturing processes. The brand utilizes specialized production methods to isolate and concentrate lutein from this natural botanical source, ensuring consistent purity and potency across batches. This controlled extraction approach distinguishes FloraGLO as a standardized ingredient compared to raw plant materials.

Is FloraGLO Lutein Max suitable for vegetarians and vegans?

FloraGLO Lutein Max is derived from Tagetes erecta flowers, making it a plant-based ingredient suitable for vegetarian and vegan diets. The production process maintains the botanical origin without animal-derived components, though consumers should verify the complete supplement formulation as other ingredients may vary by product.

How does FloraGLO Lutein Max compare to lutein from other plant sources like spinach?

FloraGLO Lutein Max is a standardized, branded extract from marigold flowers that provides consistent lutein concentration, whereas dietary sources like spinach offer variable amounts depending on growing conditions and preparation. The concentrated form in FloraGLO allows for precise dosing in supplement applications, making it more reliable for consistent nutritional intake than food sources alone.

FloraGLO Lutein Max (Tagetes erecta)

FloraGLO Lutein Max is a patented, free-form lutein derived from marigold flowers (Tagetes erecta), standardized for high bioavailability without saponification. As a macular carotenoid, lutein accumulates in the retinal pigment epithelium where it filters high-energy blue light and neutralizes reactive oxygen species to protect photoreceptor cells.

Category: Other Evidence: 2/10 Tier: Preliminary (in-vitro/animal)

FloraGLO Lutein Max (Tagetes erecta) — Hermetica Encyclopedia

Origin & History

FloraGLO Lutein Max is a branded, purified lutein extract derived from the flower petals of Tagetes erecta (marigold), a plant native to Mexico and Central America. The extract is produced through hexane extraction of dried marigold petals, followed by saponification with potassium hydroxide and crystallization to yield free lutein with typically ≥70% purity.

Historical & Cultural Context

No historical or traditional medicine uses are documented in the research for Tagetes erecta or lutein extracts. The plant is referenced only as a modern commercial source for carotenoid production.

Health Benefits

• No specific health benefits documented in the provided research for FloraGLO Lutein Max
• Research focuses solely on extraction methods and manufacturing processes
• No clinical trials or health outcomes are cited in the available data
• General lutein studies exist in broader literature but are not included in this research dossier
• Further clinical evidence would be needed to substantiate specific health claims

How It Works

Lutein absorbs high-energy blue light (wavelengths 400–500 nm) within the macula lutea, acting as a passive optical filter to reduce phototoxic stress on cone photoreceptors. As a non-provitamin A carotenoid, lutein also quenches singlet oxygen and scavenges peroxyl radicals, interrupting lipid peroxidation chains in photoreceptor outer segment membranes rich in polyunsaturated fatty acids. Lutein's free-form structure in FloraGLO Lutein Max allows direct micellarization during digestion, facilitating SR-B1 receptor-mediated uptake in the intestinal epithelium for enhanced plasma and retinal tissue delivery.

Scientific Research

The research dossier contains no human clinical trials, RCTs, or meta-analyses for FloraGLO Lutein Max. Available data focuses exclusively on extraction and manufacturing methods, with no PubMed PMIDs for clinical outcomes provided.

Clinical Summary

Broad lutein research, including the AREDS2 randomized controlled trial (n=4,203), demonstrated that 10 mg/day lutein combined with zeaxanthin reduced progression to advanced age-related macular degeneration (AMD) by approximately 26% in participants with low baseline dietary lutein intake. Smaller controlled studies using free-form lutein formulations report measurable increases in macular pigment optical density (MPOD) within 3–6 months of supplementation at 10–20 mg/day. Evidence specifically validating FloraGLO Lutein Max as a distinct formulation beyond its extraction process is limited in the currently available dataset, and outcomes cited derive from general lutein literature. Overall evidence for lutein in eye health is considered moderate-to-strong for AMD risk reduction, but direct head-to-head trials comparing FloraGLO Lutein Max to other lutein forms are not yet publicly established.

Nutritional Profile

FloraGLO Lutein Max is a concentrated lutein extract derived from Tagetes erecta (marigold) oleoresin, standardized to contain approximately 20% free lutein (typically ~200 mg/g) with naturally co-occurring zeaxanthin at roughly a 5:1 lutein-to-zeaxanthin ratio. The primary bioactive compounds are xanthophyll carotenoids, specifically (3R,3'R,6'R)-lutein (the naturally occurring stereoisomer) and (3R,3'S)-meso-zeaxanthin as well as (3R,3'R)-zeaxanthin in smaller quantities. The extract is lipophilic and is typically delivered in a vegetable oil suspension (e.g., safflower oil or medium-chain triglycerides) to enhance bioavailability. As a concentrated carotenoid ingredient rather than a whole food, it does not provide significant macronutrients (protein, carbohydrates, or fiber) in typical serving doses (6–20 mg lutein per dose). Trace amounts of other marigold-derived carotenoids and plant lipids may be present. Fat-soluble nature means bioavailability is substantially improved (up to 2–3 fold) when consumed with dietary fat (≥3–5 g). The FloraGLO formulation uses a proprietary crystalline free-form lutein (non-esterified), which some evidence suggests may be more readily absorbed than esterified lutein forms, as it does not require intestinal esterase cleavage prior to absorption. The product contains no appreciable vitamins, minerals, or dietary fiber. Caloric contribution per serving is negligible (<5 kcal). The extract may contain residual saponification by-products and food-grade processing aids at levels compliant with regulatory specifications. Typical finished product specifications include total carotenoids ≥85% (by weight of the oleoresin concentrate before suspension), with lutein purity confirmed via HPLC. The ingredient is Generally Recognized as Safe (GRAS) in the United States and is used globally as a dietary supplement ingredient and food colorant.

Preparation & Dosage

No clinically studied dosage ranges are provided in the research for FloraGLO Lutein Max or Tagetes erecta extracts. Manufacturing targets ≥70% lutein content via purity assays, but no specific human dosing information is available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients documented in available research

Safety & Interactions

Lutein is generally recognized as safe (GRAS) at doses up to 20 mg/day, with no serious adverse events reported in long-term trials including AREDS2 spanning five years. High-dose supplementation (above 20 mg/day) may cause carotenodermia, a benign yellowing of the skin that resolves upon dose reduction. Lutein may theoretically compete with beta-carotene for intestinal absorption via shared micellar pathways and SR-B1 receptors, potentially reducing beta-carotene status when taken simultaneously in high amounts. No clinically significant drug interactions have been established, but individuals on cholesterol-lowering medications such as cholestyramine should be aware that fat absorption inhibitors may reduce lutein bioavailability; pregnant women are generally advised to consult a physician before supplementing beyond dietary levels.